GlycoMimetics Inc (NASDAQ:GLYC) soared 98.70% during previous trade, a total of 36.83M shares exchanged hands compared with its average trading volume of 105,231 shares whereas its relative volume is 501.88. The stock has a market capitalization of $262.91M along with 24.64M outstanding shares. Stock’s intraday price range hit the peak level of $11.58 and touched the lowest level of $7.21.

Most recently GlycoMimetics Inc (NASDAQ:GLYC)’s price target was revised on 05/08/17 and according to 4 analysts stock’s price will reach at $12.50 during 52 weeks with standard deviation of 3.51. Stock’s minimum price target estimates has been figured out at $9 while the maximum price target forecast is established at $16, if we look at the price target with an optimistic approach it has upside potential of 50% from its latest closing price of $10.67.

Historically, if we look at price target revisions, two weeks ago GlycoMimetics Inc (NASDAQ:GLYC)’s price target was revised on 03/01/17 by the analysts, however the bullish price estimates of the stock set at $16 while the bearish estimates kept at $9 over the next one year. Stock’s 52-week target was retained at $13.33, the estimates indicates a standard deviation of 3.79.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1. ABR value is precisely based on brokerage recommendations, where out of 4 brokerage recommendations 4 rate GlycoMimetics Inc (NASDAQ:GLYC) stock a Strong Buy, 0 rate the stocks of the company a Buy, 0 rate Hold, 0 rate Sell and 0 recommend a Strong Sell.

GlycoMimetics Inc (NASDAQ:GLYC) performance over the past one year soared 64.15% whereas its year to date (YTD) performance indicated a bullish trend of 74.92%. During the last six months the stock climbed 63.65%. Quarterly performance of the company shows optimistic momentum of 66.98% while its last one month trend is positive with 133.99%. Stock’s weekly performance expressed up trend of 162.16%.

The company’s price sits 111.38% above from its 50-day moving average of $4.57 and 71.68% far from the stock’s 200-day moving average which is $5.77.

According to consensus agreement of 5 analysts GlycoMimetics Inc (NASDAQ:GLYC) will report earnings per share of $-0.37 in their quarterly report and it is expected to announce the company’s results on 8/3/17. For the current quarter the company has high EPS estimates of $-0.34 in contradiction of low EPS estimates of $-0.4. However a year ago for the same quarter the company has reported $-0.41 EPS. Current year EPS projections for GlycoMimetics Inc (NASDAQ:GLYC) set at $-1.41 according to the sentiments of 5 analysts, while its lowest earnings estimates are $-1.61 and highest earnings estimates are $-1.29.